What will happen to registered EU trade mark rights after 31 December 2020?
It is important to note that as the UK leaves the European Union, EU trade marks (EUTMs) will still be valid in the other 27 member countries of the EU: Austria, Belgium, Bulgaria, Croatia, Cyprus,… read more…
Mathys & Squire’s medical software client, Transformative AI, raises $1.7 million seed round
We are delighted to announce that our client, medical software company Transformative AI, has raised a $17 million seed round The investment, which was led by Tera Ventures and included funding from… read more…
Are your IP agreements Brexit proof?
The UK’s exit from the EU may have an effect on all types of intellectual property (IP) where there are existing agreements or licences in place The UK is currently in a transition period until 31… read more…
German ‘webinar’ trade mark – what’s behind the rumours?
During these challenging coronavirus times, digital life is at its peak – with people meeting, working and learning digitally from home Accordingly, more and more online seminars, so called… read more…
Latest developments on the unitary patent system
Background The efforts to create a unified patent system in Europe are now well advanced The agreement on a unified European Patent Court has been coordinated at European level and is now… read more…
Volte-face: EPO’s G3/19 decision
In this article for Intellectual Property Magazine, Mathys & Squire associate Alexander Robinson analyses the implications of the EPO’s high-profile plant and animal ruling reversal In a… read more…
EPO’s Enlarged Board hearing G 1/19 – patentability of computer simulation inventions
Today (15 July 2020) saw the hearing of the EPO Enlarged Board of Appeal in G 1/19 – only the second such hearing ever relating to Computer Implemented Inventions (CIIs) at the EPO While the… read more…
EPO’s G3/19 decision: no turning back?
The EPO’s May 2020 decision in G3/19, on the patentability of certain plants, was among the most controversial in the office’s history In this article for Life Sciences Intellectual Property… read more…
CJEU restricts SPCs for new uses of previously authorised products
The Court of Justice of the European Union (CJEU), the EU’s highest court, has issued its decision in case C-673/18 (Santen) The ruling relates to the interpretation of Article 3(d) of the… read more…
